# Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS

> **NCT04739384** · PHASE3 · COMPLETED · sponsor: **Federico II University** · enrollment: 50 (actual)

## Conditions studied

- Acute Coronary Syndrome
- STEMI
- NSTEMI
- Coronary Artery Disease
- Myocardial Infarction

## Interventions

- **DRUG:** Ticagrelor 90mg
- **DRUG:** Ticagrelor 60 mg

## Key facts

- **NCT ID:** NCT04739384
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-06-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04739384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04739384, "Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04739384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*